Drug
Anrikefon
Anrikefon is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_2
1
33%
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Not yet recruiting2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 42 (66.7%)
Trials by Status
not_yet_recruiting267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
not_yet_recruitingphase_2
A Study on the Efficacy and Safety of Anrikefon for Postoperative Pain Relief Following Laparoscopic Cholecystectomy
NCT07741188
not_yet_recruitingphase_4
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
NCT07380113
recruitingphase_4
Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery
NCT07269106
Clinical Trials (3)
Showing 3 of 3 trials
NCT07741188Phase 2
A Study on the Efficacy and Safety of Anrikefon for Postoperative Pain Relief Following Laparoscopic Cholecystectomy
NCT07380113Phase 4
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
NCT07269106Phase 4
Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3